Birmingham, AL18 Active Studies

Cystic Fibrosis Clinical Trials in Birmingham, AL

Find 18 actively recruiting cystic fibrosis clinical trials in Birmingham, AL. Connect with local research sites and explore new treatment options.

18
Active Trials
16
Sponsors
3,945
Enrolling

Recruiting Cystic Fibrosis Studies in Birmingham

About Cystic Fibrosis Clinical Trials in Birmingham

Cystic fibrosis is a genetic disorder that causes thick, sticky mucus to build up in the lungs, digestive tract, and other organs. It is caused by mutations in the CFTR gene. CFTR modulator therapies have dramatically improved outcomes, along with airway clearance techniques and nutritional support.

There are currently 18 cystic fibrosis clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 3,945 participants. Research is being sponsored by Chris Goss, George Solomon, University of Washington, the Collaborative Health Studies Coordinating Center and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Cystic Fibrosis Clinical Trials in Birmingham — FAQ

Are there cystic fibrosis clinical trials in Birmingham?

Yes, there are 18 cystic fibrosis clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What cystic fibrosis treatments are being tested?

The 18 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for cystic fibrosis.

Data updated July 17, 2026 from ClinicalTrials.gov